NCCS Research Committee
Members of the NCCS Research Committee – 1 July 2024 to 30 June 2026
| Core Members | |
A/Prof Tam Wai Leong |
Deputy Chief Executive Officer (Research), NCCS Principal Investigator, Laboratory of Cancer Epigenome |
| Professor Lim Soon Thye |
Chief Executive Officer, NCCS |
| Professor Teh Bin Tean | Deputy Chief Executive Officer (Enterprise & Venture), NCCS |
| Professor N.Gopalakrishna Iyer | Head, Division of Medical Sciences |
| A/Prof Ong Choon Kiat |
Head, Cellular & Molecular Research |
| Professor Daniel Tan | Head, Clinical Trials & Epidemiological Sciences |
A/Professor Henry Ho (wef 1 Apr 2022) Alternate: A/Prof Johnny Ong |
Div Chair, Division of Surgery and Surgical Oncology, SGH & NCCS |
Professor Ravindran Kanesvaran Alternate: Asst Prof Jason Chan |
Div Chair, Division of Medical Oncology, NCCS |
Clin Asst Professor Michael Wang Alternate: Clin Asst Prof Jeffrey Tuan |
Div Chair, Division of Radiation Oncology, NCCS |
Clin Asst Prof Tiffany Hennedige Alternate: Clin Asst Prof Chan Wan Ying |
HOD, Division ofOncologic Imaging, NCCS |
Clin Asst Prof Shirlynn Ho (wef 1 July 2024) Alternate: A/Prof Grace Yang |
HOD, Division of Supportive and Palliative Care, NCCS |
| Professor Ng Heng Joo (wef 1 Feb 2025) Alternate: Clin Assoc Prof Chandramouli Nagarajan |
HOD, Haematology |
| Non-Voting Ex Officio Members | |
| Mr Chong Pang Boon | Chief Operating Officer, NCCS |
| Ms Geraldine Ong | Chief Financial Officer, NCCS |
| Professor Rebecca Dent |
Deputy Chief Executive Officer (Clinical), NCCS |
| Dr Elaine Lim (wed 1 May 2019) |
Director, Division of Community Outreach and Philanthropy, NCCS |
| Professor Toh Han Chong | Deputy Chief Executive Officer (Strategic Partnerships), NCCS |
| Professor Ong Sin Tiong | Professor, CSCB, Duke-NUS |
| Professor Balram Chowbay | Principal Pharmacologist, Clinical Pharmacology Lab, NCCS |
| Mr Martin Tan | Director, Research Administration, NCCS |
NCCS Scientific Advisory Board
| Professor Webster K. Cavenee Emeritus Professor, Medicine, University of California San Diego |
 |
| Professor Michael B. Kastan Executive Director, Duke Cancer Institute William and Jane Shingleton Distinguished Professor, Pharmacology and Cancer Biology Professor of Pediatrics Duke University School of Medicine |
 |
| Professor Patrick Maxwell Regius Professor of Physic and Head of the School of Clinical Medicine University of Cambridge |
 |
| Professor Timothy A. Yap Ransom Horne, Jr. Endowed Professor for Cancer Research Head of Clinical Development, Vice President, Therapeutics Discovery Division Professor, Investigational Cancer Therapeutics (Phase I Program), Division of Cancer Medicine The University of Texas MD Anderson Cancer Center |
 |
Stay Healthy The Easy Way
Get trusted health advice, offers and more.
Stay Ahead in Healthcare Industry
Subscribe to our exclusive updates for healthcare professionals.
Keep Healthy With
HealthXchange
Health Videos
© 2025 SingHealth Group. All Rights Reserved.